celecoxib has been researched along with Acute Disease in 46 studies
Acute Disease: Disease having a short and relatively severe course.
| Excerpt | Relevance | Reference |
|---|---|---|
| "In this double blind, placebo controlled, parallel group study, patients with acute onset shoulder tendinitis and/or subacromial bursitis were randomized to receive one of: celecoxib 400 mg followed by 200 mg bid, naproxen 500 mg bid, or placebo bid for 14 days." | 9.11 | Celecoxib effectively treats patients with acute shoulder tendinitis/bursitis. ( Cui, H; Hufman, SL; Petri, M; Snabes, MC; Verburg, KM; Waser, G, 2004) |
| "In this single-blind, controlled trial, consecutively hospitalized elderly patients (age > or = 70 years) with inflammation (C-reactive protein [CRP] levels > or =10 mg/L) due to acute infection were randomly assigned to receive 2 weeks of treatment with the COX-2-selective inhibitor celecoxib, acetaminophen, or no supplementary medication (control)." | 9.11 | The influence of celecoxib on muscle fatigue resistance and mobility in elderly patients with inflammation. ( Bautmans, I; Demanet, C; Lambert, M; Mets, T; Njemini, R, 2004) |
| "No significant difference exists among emergency department (ED) patients treated for acute pain, at five hours, with celecoxib 200 mg, celecoxib 400 mg, or ibuprofen 600 mg, though the power of the study to detect a change was low, 36%." | 9.10 | A randomized, clinical trial comparing oral celecoxib 200 mg, celecoxib 400 mg, and ibuprofen 600 mg for acute pain. ( Goldberg, J; Kenwood, A; Lavery, R; Salo, DF; Shapiro, T; Varma, V, 2003) |
| "Celecoxib is the first COX-2 specific inhibitor approved for use in osteoarthritis and rheumatoid arthritis." | 8.80 | Celecoxib: a review of its use in osteoarthritis, rheumatoid arthritis and acute pain. ( Clemett, D; Goa, KL, 2000) |
| "This study evaluated whether there is an association between the use of celecoxib and acute pancreatitis in Taiwan." | 7.81 | Use of celecoxib correlates with increased relative risk of acute pancreatitis: a case-control study in Taiwan. ( Hung, HC; Hung, SC; Hung, SR; Lai, SW; Lin, CL, 2015) |
| " This study was undertaken to apply the diffusion of innovations theory to the prescribing of celecoxib and to determine if prescriber and patient characteristics differed amongst early use of celecoxib for acute pain versus chronic musculoskeletal conditions." | 7.74 | Use of celecoxib immediately post marketing in Canada: acute or chronic pain? ( Kozyrskyj, AL; Racher, A; Raymond, C, 2007) |
| "Cyclovirobuxine D is an active compound extracted from Buxus microphylla, which has been used for treating acute myocardial ischemia in China." | 7.74 | Cyclovirobuxine D ameliorates acute myocardial ischemia by K(ATP) channel opening, nitric oxide release and anti-thrombosis. ( Chen, S; Hu, D; Liu, X; Wang, Y, 2007) |
| "Both membranous glomerulopathy and acute interstitial nephritis have been reported to occur following treatment with non-steroidal anti-inflammatory drugs." | 5.32 | Membranous glomerulopathy and acute interstitial nephritis following treatment with celecoxib. ( Appel, GB; D'Agati, VD; Falkowitz, DC; Imaizumi, S; Isom, R; Markowitz, GS; Zaki, M, 2003) |
| "Celecoxib, a COX-2 selective inhibitor, is as effective as diclofenac SR in treating ankle sprains." | 5.12 | Efficacy and tolerability of celecoxib compared with diclofenac slow release in the treatment of acute ankle sprain in an Asian population. ( Abrahan, L; Fakir-Bolte, C; Hwang, LJ; Lau, FL; Nadarajah, A, 2006) |
| "Celecoxib is as effective as naproxen in treating acute first-degree or second-degree ankle sprains but causes significantly less dyspepsia." | 5.11 | Efficacy of celecoxib, a COX-2-specific inhibitor, and naproxen in the management of acute ankle sprain: results of a double-blind, randomized controlled trial. ( Ekman, EF; Fort, JG; Petrella, R; Schuller, R, 2004) |
| "In this double blind, placebo controlled, parallel group study, patients with acute onset shoulder tendinitis and/or subacromial bursitis were randomized to receive one of: celecoxib 400 mg followed by 200 mg bid, naproxen 500 mg bid, or placebo bid for 14 days." | 5.11 | Celecoxib effectively treats patients with acute shoulder tendinitis/bursitis. ( Cui, H; Hufman, SL; Petri, M; Snabes, MC; Verburg, KM; Waser, G, 2004) |
| "In this single-blind, controlled trial, consecutively hospitalized elderly patients (age > or = 70 years) with inflammation (C-reactive protein [CRP] levels > or =10 mg/L) due to acute infection were randomly assigned to receive 2 weeks of treatment with the COX-2-selective inhibitor celecoxib, acetaminophen, or no supplementary medication (control)." | 5.11 | The influence of celecoxib on muscle fatigue resistance and mobility in elderly patients with inflammation. ( Bautmans, I; Demanet, C; Lambert, M; Mets, T; Njemini, R, 2004) |
| "No significant difference exists among emergency department (ED) patients treated for acute pain, at five hours, with celecoxib 200 mg, celecoxib 400 mg, or ibuprofen 600 mg, though the power of the study to detect a change was low, 36%." | 5.10 | A randomized, clinical trial comparing oral celecoxib 200 mg, celecoxib 400 mg, and ibuprofen 600 mg for acute pain. ( Goldberg, J; Kenwood, A; Lavery, R; Salo, DF; Shapiro, T; Varma, V, 2003) |
| "Celecoxib is the first COX-2 specific inhibitor approved for use in osteoarthritis and rheumatoid arthritis." | 4.80 | Celecoxib: a review of its use in osteoarthritis, rheumatoid arthritis and acute pain. ( Clemett, D; Goa, KL, 2000) |
| "This study evaluated whether there is an association between the use of celecoxib and acute pancreatitis in Taiwan." | 3.81 | Use of celecoxib correlates with increased relative risk of acute pancreatitis: a case-control study in Taiwan. ( Hung, HC; Hung, SC; Hung, SR; Lai, SW; Lin, CL, 2015) |
| " This study was undertaken to apply the diffusion of innovations theory to the prescribing of celecoxib and to determine if prescriber and patient characteristics differed amongst early use of celecoxib for acute pain versus chronic musculoskeletal conditions." | 3.74 | Use of celecoxib immediately post marketing in Canada: acute or chronic pain? ( Kozyrskyj, AL; Racher, A; Raymond, C, 2007) |
| "Cyclovirobuxine D is an active compound extracted from Buxus microphylla, which has been used for treating acute myocardial ischemia in China." | 3.74 | Cyclovirobuxine D ameliorates acute myocardial ischemia by K(ATP) channel opening, nitric oxide release and anti-thrombosis. ( Chen, S; Hu, D; Liu, X; Wang, Y, 2007) |
| "A case history is described of a 38-year-old women, without digestive past, who presented with hemorrhagic ulcerated acute colitis beginning 2 days after starting celecoxib (200 mg/d) prescribed for sciatica." | 3.73 | [Ulcerating haemorrhagic colitis induced by celecoxib]. ( Andriamanantena, D; Carrère, C; Casassus-Builhè, D; Hamant, N; Perret, JL; Rey, P, 2005) |
| "Using national data (2001-2003), this study explored the risk of acute myocardial infarction (AMI), angina, stroke and transient ischaemic attack (TIA) in long-term users of rofecoxib and celecoxib in Taiwan and compared this data with that for those using meloxicam." | 3.73 | Cardiovascular events associated with long-term use of celecoxib, rofecoxib and meloxicam in Taiwan: an observational study. ( Hsiao, FY; Huang, WF; Shih, YT; Tsai, YW; Wen, YW, 2006) |
| "The effect of valeryl salicylate (VS), an inhibitor of cyclooxygenase-1 (COX-1), was evaluated in arachidonic acid or croton oil-induced ear oedema and carrageenan-induced paw oedema in mice." | 3.72 | Effects of valeryl salicylate, a COX-1 inhibitor, on models of acute inflammation in mice. ( Brum-Fernandes, AJ; Peters, RR; Ribeiro-do-Valle, RM; Siqueira-Junior, JM, 2003) |
| "This is the fourth report in the English-language literature describing cholestatic hepatitis temporally related to celecoxib use, the second supported by histologic findings typical of drug-induced cholestasis, and the first in a patient who denied use of alcoholic beverages and was taking no other drugs or herbal products at the time of the reaction." | 3.71 | Acute cholestatic hepatitis associated with celecoxib. ( Civello, IM; Gasbarrini, G; Giorgi, A; Grieco, A; Miele, L, 2002) |
| "Subjects treated a single migraine attack with 120 mg DFN-15 or placebo as soon as possible after the onset of pain of moderate to severe intensity." | 2.94 | Efficacy, Tolerability, and Safety of DFN-15 (Celecoxib Oral Solution, 25 mg/mL) in the Acute Treatment of Episodic Migraine: A Randomized, Double-Blind, Placebo-Controlled Study. ( Brand-Schieber, E; Dodick, DW; Lipton, RB; Munjal, S; Tepper, SJ, 2020) |
| " The onset of analgesia (PID >or= 1) for all CS-706 doses occurred within 1 hour after dosing (P<0." | 2.73 | A randomized, double-blind, celecoxib- and placebo-controlled study of the effectiveness of CS-706 in acute postoperative dental pain. ( Bandy, DP; Daniels, SE; Desjardins, PJ; Lawson, JE; Link, AJ; Moberly, JB; Truitt, KE; Xu, J, 2007) |
| "Migraine is a common disabling condition that results in considerable socioeconomic loss." | 2.73 | Randomised, open label, controlled trial of celecoxib in the treatment of acute migraine. ( Loo, CY; Raymond, AA; Tan, HJ; Teh, HS, 2007) |
| "Celecoxib was discontinued and the patient's renal function improved to a discharge creatine of 205-220 µmol/L." | 1.46 | Cyclooxygenase-2 inhibitor-induced acute interstitial nephritis. ( Albrecht, B; Giebel, S; McCarron, M; Prasad, B, 2017) |
| "Pretreatment with celecoxib resulted in a significant reduction in TNF-α levels and an increase in NO(x) and NOS levels compared with the AMI group." | 1.38 | Low-dose celecoxib improves coronary function after acute myocardial ischaemia in rabbits. ( Bi, XY; He, X; Li, DL; Liu, JJ; Ma, X; Yu, XJ; Zang, WJ; Zhang, HL; Zhao, M, 2012) |
| "Both membranous glomerulopathy and acute interstitial nephritis have been reported to occur following treatment with non-steroidal anti-inflammatory drugs." | 1.32 | Membranous glomerulopathy and acute interstitial nephritis following treatment with celecoxib. ( Appel, GB; D'Agati, VD; Falkowitz, DC; Imaizumi, S; Isom, R; Markowitz, GS; Zaki, M, 2003) |
| "We present two cases of acute renal failure complicating the course of therapy with celecoxib in patients with chronic renal insufficiency." | 1.31 | Are selective COX-2 inhibitors nephrotoxic? ( Eras, J; Perazella, MA, 2000) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 38 (82.61) | 29.6817 |
| 2010's | 7 (15.22) | 24.3611 |
| 2020's | 1 (2.17) | 2.80 |
| Authors | Studies |
|---|---|
| Khanapure, SP | 1 |
| Garvey, DS | 1 |
| Young, DV | 1 |
| Ezawa, M | 1 |
| Earl, RA | 1 |
| Gaston, RD | 1 |
| Fang, X | 1 |
| Murty, M | 1 |
| Martino, A | 1 |
| Shumway, M | 1 |
| Trocha, M | 1 |
| Marek, P | 1 |
| Tam, SW | 1 |
| Janero, DR | 1 |
| Letts, LG | 1 |
| Lipton, RB | 1 |
| Munjal, S | 1 |
| Brand-Schieber, E | 1 |
| Tepper, SJ | 1 |
| Dodick, DW | 1 |
| Albrecht, B | 1 |
| Giebel, S | 1 |
| McCarron, M | 1 |
| Prasad, B | 1 |
| Hung, SC | 1 |
| Hung, SR | 1 |
| Lin, CL | 1 |
| Lai, SW | 1 |
| Hung, HC | 1 |
| Phillips, E | 1 |
| Hinck, B | 1 |
| Pedro, R | 1 |
| Makhlouf, A | 1 |
| Kriedberg, C | 1 |
| Hendlin, K | 1 |
| Monga, M | 1 |
| Khayyal, MT | 1 |
| El-Ghazaly, MA | 1 |
| El-Hazek, RM | 1 |
| Nada, AS | 1 |
| Fiorelli, VM | 1 |
| Bhat, P | 1 |
| Foster, CS | 1 |
| Clarke, H | 1 |
| Kay, J | 1 |
| Mitsakakis, N | 1 |
| Katz, J | 1 |
| Lee, CH | 1 |
| Wang, JD | 1 |
| Chen, PC | 1 |
| Kellner, H | 1 |
| Zhao, M | 2 |
| He, X | 1 |
| Bi, XY | 1 |
| Zhang, HL | 1 |
| Yu, XJ | 1 |
| Liu, JJ | 1 |
| Li, DL | 1 |
| Ma, X | 1 |
| Zang, WJ | 1 |
| Alper, AB | 1 |
| Meleg-Smith, S | 1 |
| Krane, NK | 1 |
| Rowbotham, DJ | 1 |
| Grieco, A | 1 |
| Miele, L | 1 |
| Giorgi, A | 1 |
| Civello, IM | 1 |
| Gasbarrini, G | 1 |
| Salo, DF | 1 |
| Lavery, R | 1 |
| Varma, V | 1 |
| Goldberg, J | 1 |
| Shapiro, T | 1 |
| Kenwood, A | 1 |
| Nind, G | 1 |
| Selby, W | 1 |
| Markowitz, GS | 1 |
| Falkowitz, DC | 1 |
| Isom, R | 1 |
| Zaki, M | 1 |
| Imaizumi, S | 1 |
| Appel, GB | 1 |
| D'Agati, VD | 1 |
| Siqueira-Junior, JM | 1 |
| Peters, RR | 1 |
| Brum-Fernandes, AJ | 1 |
| Ribeiro-do-Valle, RM | 1 |
| Coulter, DM | 1 |
| Clark, DW | 1 |
| Savage, RL | 1 |
| Burian, M | 1 |
| Geisslinger, G | 1 |
| Brewster, UC | 1 |
| Perazella, MA | 2 |
| Jayr, C | 1 |
| Petrella, R | 1 |
| Ekman, EF | 1 |
| Schuller, R | 1 |
| Fort, JG | 1 |
| Petri, M | 1 |
| Hufman, SL | 1 |
| Waser, G | 1 |
| Cui, H | 1 |
| Snabes, MC | 1 |
| Verburg, KM | 1 |
| Pearson, RL | 1 |
| Rey, P | 1 |
| Andriamanantena, D | 1 |
| Carrère, C | 1 |
| Casassus-Builhè, D | 1 |
| Hamant, N | 1 |
| Perret, JL | 1 |
| Mets, T | 1 |
| Bautmans, I | 1 |
| Njemini, R | 1 |
| Lambert, M | 1 |
| Demanet, C | 1 |
| Krüger, K | 1 |
| Klasser, GD | 1 |
| Epstein, J | 1 |
| Houmani, Z | 1 |
| Imbert, A | 1 |
| Duchmann, JC | 1 |
| Messerschmitt, C | 1 |
| Barbare, JC | 1 |
| Latrive, JP | 1 |
| Biour, M | 1 |
| Huang, WF | 1 |
| Hsiao, FY | 1 |
| Tsai, YW | 1 |
| Wen, YW | 1 |
| Shih, YT | 1 |
| Nadarajah, A | 1 |
| Abrahan, L | 1 |
| Lau, FL | 1 |
| Hwang, LJ | 1 |
| Fakir-Bolte, C | 1 |
| Desouza, IA | 1 |
| Franco-Penteado, CF | 1 |
| Camargo, EA | 1 |
| Lima, CS | 1 |
| Teixeira, SA | 1 |
| Muscará, MN | 1 |
| De Nucci, G | 1 |
| Antunes, E | 1 |
| Kozyrskyj, AL | 1 |
| Raymond, C | 1 |
| Racher, A | 1 |
| Hu, D | 1 |
| Liu, X | 1 |
| Wang, Y | 1 |
| Chen, S | 1 |
| Moberly, JB | 1 |
| Xu, J | 1 |
| Desjardins, PJ | 1 |
| Daniels, SE | 1 |
| Bandy, DP | 1 |
| Lawson, JE | 1 |
| Link, AJ | 1 |
| Truitt, KE | 1 |
| Loo, CY | 1 |
| Tan, HJ | 1 |
| Teh, HS | 1 |
| Raymond, AA | 1 |
| Frampton, JE | 1 |
| Keating, GM | 1 |
| Audia, P | 1 |
| Feinfeld, DA | 1 |
| Dubrow, A | 1 |
| Winchester, JF | 1 |
| Carrillo-Jimenez, R | 1 |
| Nurnberger, M | 1 |
| Baciewicz, AM | 1 |
| Sokos, DR | 1 |
| King, TJ | 1 |
| Eras, J | 1 |
| Clemett, D | 1 |
| Goa, KL | 1 |
| Lantz, MS | 1 |
| Giambanco, V | 1 |
| Cannon, GW | 1 |
| Breedveld, FC | 1 |
| Kessenich, CR | 1 |
10 reviews available for celecoxib and Acute Disease
| Article | Year |
|---|---|
COX-2-selective inhibitors: clinical relevance in surgical and acute pain.
Topics: Acute Disease; Analgesics; Animals; Celecoxib; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cycloo | 2002 |
Celecoxib, rofecoxib, and acute temporary visual impairment.
Topics: Acute Disease; Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Celecoxib; Cyclooxy | 2003 |
[Clinical pharmacology of the selective COX-2 inhibitors].
Topics: Acute Disease; Administration, Oral; Adult; Aged; Anti-Inflammatory Agents, Non-Steroidal; Arthritis | 2003 |
[Analgesic effects of cyclooxygenase 2 inhibitors].
Topics: Acute Disease; Analgesics; Anti-Inflammatory Agents, Non-Steroidal; Celecoxib; Chronic Disease; Cycl | 2004 |
[The efficacy of selective Cox-2-inhibitors in comparison with conventional NSAIDs].
Topics: Acute Disease; Anti-Inflammatory Agents, Non-Steroidal; Antirheumatic Agents; Arthritis; Arthritis, | 2005 |
Nonsteroidal anti-inflammatory drugs: confusion, controversy and dental implications.
Topics: Acute Disease; Anti-Inflammatory Agents, Non-Steroidal; Celecoxib; Chronic Disease; Clinical Trials | 2005 |
Celecoxib: a review of its use in the management of arthritis and acute pain.
Topics: Acute Disease; Arthritis; Celecoxib; Cyclooxygenase 2 Inhibitors; Humans; Pain; Pyrazoles; Sulfonami | 2007 |
Celecoxib: a review of its use in osteoarthritis, rheumatoid arthritis and acute pain.
Topics: Acute Disease; Animals; Arthritis, Rheumatoid; Celecoxib; Cyclooxygenase Inhibitors; Electron Transp | 2000 |
Efficacy of cyclooxygenase-2-specific inhibitors.
Topics: Acute Disease; Anti-Inflammatory Agents, Non-Steroidal; Arthritis, Rheumatoid; Celecoxib; Cyclooxyge | 2001 |
Cyclo-oxygenase 2 inhibitors: an important new drug classification.
Topics: Acute Disease; Analgesics; Anti-Inflammatory Agents, Non-Steroidal; Arachidonic Acid; Celecoxib; Chr | 2001 |
11 trials available for celecoxib and Acute Disease
| Article | Year |
|---|---|
Efficacy, Tolerability, and Safety of DFN-15 (Celecoxib Oral Solution, 25 mg/mL) in the Acute Treatment of Episodic Migraine: A Randomized, Double-Blind, Placebo-Controlled Study.
Topics: Acute Disease; Adult; Celecoxib; Cyclooxygenase 2 Inhibitors; Double-Blind Method; Female; Humans; M | 2020 |
Celecoxib in the management of acute renal colic: a randomized controlled clinical trial.
Topics: Acute Disease; Adult; Celecoxib; Colic; Cyclooxygenase Inhibitors; Double-Blind Method; Female; Huma | 2009 |
Acute pain after total hip arthroplasty does not predict the development of chronic postsurgical pain 6 months later.
Topics: Acetaminophen; Acute Disease; Adolescent; Adult; Aged; Arthroplasty, Replacement, Hip; Celecoxib; Ch | 2010 |
A randomized, clinical trial comparing oral celecoxib 200 mg, celecoxib 400 mg, and ibuprofen 600 mg for acute pain.
Topics: Acute Disease; Adult; Celecoxib; Cyclooxygenase Inhibitors; Dose-Response Relationship, Drug; Double | 2003 |
Efficacy of celecoxib, a COX-2-specific inhibitor, and naproxen in the management of acute ankle sprain: results of a double-blind, randomized controlled trial.
Topics: Acute Disease; Adult; Ankle Injuries; Celecoxib; Cyclooxygenase Inhibitors; Double-Blind Method; Fem | 2004 |
Celecoxib effectively treats patients with acute shoulder tendinitis/bursitis.
Topics: Acute Disease; Adult; Aged; Aged, 80 and over; Bursitis; Celecoxib; Cyclooxygenase Inhibitors; Doubl | 2004 |
Re: Efficacy of celecoxib, a COX-2-specific inhibitor, and naproxen in the management of acute ankle sprain: results of a double-blind, randomized controlled trial.
Topics: Acute Disease; Administration, Oral; Ankle Injuries; Celecoxib; Cyclooxygenase Inhibitors; Dose-Resp | 2005 |
The influence of celecoxib on muscle fatigue resistance and mobility in elderly patients with inflammation.
Topics: Acute Disease; Aged; Aged, 80 and over; C-Reactive Protein; Celecoxib; Cyclooxygenase Inhibitors; Cy | 2004 |
Efficacy and tolerability of celecoxib compared with diclofenac slow release in the treatment of acute ankle sprain in an Asian population.
Topics: Acute Disease; Adult; Ankle Injuries; Anti-Inflammatory Agents, Non-Steroidal; Asia; Blood Platelets | 2006 |
A randomized, double-blind, celecoxib- and placebo-controlled study of the effectiveness of CS-706 in acute postoperative dental pain.
Topics: Acute Disease; Adolescent; Adult; Celecoxib; Cyclooxygenase 2 Inhibitors; Dose-Response Relationship | 2007 |
Randomised, open label, controlled trial of celecoxib in the treatment of acute migraine.
Topics: Acute Disease; Adult; Celecoxib; Cyclooxygenase 2 Inhibitors; Female; Humans; Male; Migraine Disorde | 2007 |
25 other studies available for celecoxib and Acute Disease
| Article | Year |
|---|---|
Synthesis and structure-activity relationship of novel, highly potent metharyl and methcycloalkyl cyclooxygenase-2 (COX-2) selective inhibitors.
Topics: Acute Disease; Administration, Oral; Animals; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cycloox | 2003 |
Cyclooxygenase-2 inhibitor-induced acute interstitial nephritis.
Topics: Acute Disease; Celecoxib; Cyclooxygenase 2 Inhibitors; Female; Humans; Middle Aged; Nephritis, Inter | 2017 |
Use of celecoxib correlates with increased relative risk of acute pancreatitis: a case-control study in Taiwan.
Topics: Acute Disease; Adult; Aged; Aged, 80 and over; Alcohol-Related Disorders; Cardiovascular Diseases; C | 2015 |
The effects of celecoxib, a COX-2 selective inhibitor, on acute inflammation induced in irradiated rats.
Topics: Acute Disease; Animals; Anti-Inflammatory Agents; Celecoxib; Cyclooxygenase 2 Inhibitors; Cyclooxyge | 2009 |
Nonsteroidal anti-inflammatory therapy and recurrent acute anterior uveitis.
Topics: Acute Disease; Adult; Anti-Inflammatory Agents, Non-Steroidal; Celecoxib; Diflunisal; Female; HLA-B2 | 2010 |
Increased risk of hospitalization for acute hepatitis in patients with previous exposure to NSAIDs.
Topics: Acute Disease; Adolescent; Adult; Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; | 2010 |
["Rheumatic pain". Joint is painfully swollen overnight].
Topics: Acute Disease; Adult; Allopurinol; Ankle Joint; Anti-Inflammatory Agents, Non-Steroidal; Arthralgia; | 2010 |
Low-dose celecoxib improves coronary function after acute myocardial ischaemia in rabbits.
Topics: Acute Disease; Animals; Celecoxib; Coronary Vessels; Cyclooxygenase 2 Inhibitors; Dose-Response Rela | 2012 |
Nephrotic syndrome and interstitial nephritis associated with celecoxib.
Topics: Acute Disease; Anti-Inflammatory Agents, Non-Steroidal; Arthritis; Celecoxib; Cyclooxygenase 2; Cycl | 2002 |
Acute cholestatic hepatitis associated with celecoxib.
Topics: Acute Disease; Adult; Alanine Transaminase; Anti-Inflammatory Agents, Non-Steroidal; Aspartate Amino | 2002 |
Acute pancreatitis: a rare complication of celecoxib.
Topics: Acute Disease; Aged; Anti-Inflammatory Agents, Non-Steroidal; Celecoxib; Cyclooxygenase Inhibitors; | 2002 |
Membranous glomerulopathy and acute interstitial nephritis following treatment with celecoxib.
Topics: Acute Disease; Aged; Anti-Inflammatory Agents, Non-Steroidal; Arthritis, Rheumatoid; Celecoxib; Fema | 2003 |
Effects of valeryl salicylate, a COX-1 inhibitor, on models of acute inflammation in mice.
Topics: Acute Disease; Animals; Arachidonic Acid; Carrageenan; Celecoxib; Croton Oil; Cyclooxygenase 1; Cycl | 2003 |
Acute tubulointerstitial nephritis associated with celecoxib.
Topics: Acute Disease; Adult; Celecoxib; Cyclooxygenase Inhibitors; Humans; Male; Nephritis, Interstitial; P | 2004 |
[Ulcerating haemorrhagic colitis induced by celecoxib].
Topics: Acute Disease; Adult; Anti-Inflammatory Agents, Non-Steroidal; Celecoxib; Colitis, Ulcerative; Femal | 2005 |
[Acute colitis closely following the beginning of celecoxib treatment].
Topics: Acute Disease; Aged, 80 and over; Alanine Transaminase; Anti-Inflammatory Agents, Non-Steroidal; Bac | 2005 |
Cardiovascular events associated with long-term use of celecoxib, rofecoxib and meloxicam in Taiwan: an observational study.
Topics: Acute Disease; Adult; Aged; Aged, 80 and over; Angina Pectoris; Cardiovascular Diseases; Celecoxib; | 2006 |
Acute pulmonary inflammation induced by exposure of the airways to staphylococcal enterotoxin type B in rats.
Topics: Acute Disease; Animals; Anti-Inflammatory Agents; Benzoquinones; Bone Marrow; Bronchoalveolar Lavage | 2006 |
Use of celecoxib immediately post marketing in Canada: acute or chronic pain?
Topics: Acute Disease; Adult; Aged; Canada; Celecoxib; Chronic Disease; Cyclooxygenase 2 Inhibitors; Diffusi | 2007 |
Cyclovirobuxine D ameliorates acute myocardial ischemia by K(ATP) channel opening, nitric oxide release and anti-thrombosis.
Topics: Acute Disease; Animals; Animals, Newborn; Celecoxib; Cell Hypoxia; Cell Survival; Cells, Cultured; C | 2007 |
Metformin-induced lactic acidosis and acute pancreatitis precipitated by diuretic, celecoxib, and candesartan-associated acute kidney dysfunction.
Topics: Acidosis, Lactic; Acute Disease; Acute Kidney Injury; Angiotensin II Type 1 Receptor Blockers; Benzi | 2008 |
Celecoxib-induced acute pancreatitis and hepatitis: a case report.
Topics: Acute Disease; Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Celecoxib; Chemical | 2000 |
Acute pancreatitis associated with celecoxib.
Topics: Acute Disease; Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Celecoxib; Humans; | 2000 |
Are selective COX-2 inhibitors nephrotoxic?
Topics: Acute Disease; Aged; Celecoxib; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibi | 2000 |
Acute onset of auditory hallucinations after initiation of celecoxib therapy.
Topics: Acute Disease; Aged; Anti-Inflammatory Agents, Non-Steroidal; Celecoxib; Cyclooxygenase Inhibitors; | 2000 |